MarketPeel
Insider Trading Intelligence
RM

Richard Malamut

COLL
EVP AND CHIEF MEDICAL OFFICER · COLLEGIUM PHARMACEUTICAL, INC · CIK 0001772168
FILING MIX · LIFETIME64%/36%
BUYS
14
SELLS
8
TOTAL VALUE
$301.2K
COMPANIES
2
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
158,010
AVG SELL PX
$19.78
TRADE KIND
SHOWING 22 / 22
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 6 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Richard Malamut, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+0.00%+10.69%+3.67%+7.01%+7.01%
14d2+0.00%+12.74%+6.99%+5.76%+5.76%
30d2+0.00%+22.55%+9.88%+12.66%+12.66%
60d2+0.00%+29.75%
90d2+0.00%+42.30%+13.87%+28.44%+28.44%
180d2(2 pending)
1y2(2 pending)
2y2(2 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
COLL · 130,308 shares · as of Feb 10, 2022
034,14168,282102,423136,56420212022SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 14 buys / 8 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PTHS
PELTHOS THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
280$21.36$6.0K27,422Apr 2, 2026Apr 6, 2026View →
PTHS
PELTHOS THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
310$20.51$6.4K27,702Apr 2, 2026Apr 6, 2026View →
PTHS
PELTHOS THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
2,4548,904Nov 13, 2025Apr 1, 2026View →
PTHS
PELTHOS THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
58,23058,230Jul 2, 2025Jul 7, 2025View →
PTHS
PELTHOS THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
19,10828,012Jul 2, 2025Jul 7, 2025View →
PTHS
PELTHOS THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
19,10828,012Jul 2, 2025Apr 1, 2026View →
PTHS
PELTHOS THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
6,4506,450Jun 14, 2024Apr 1, 2026View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP and Chief Medical Officer
1,838$17.63$32.4K130,264Feb 10, 2022Feb 14, 2022View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP and Chief Medical Officer
4,462$17.63$78.7K132,102Feb 10, 2022Feb 14, 2022View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
6,256136,564Feb 10, 2022Feb 14, 2022View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
36,750130,308Feb 10, 2022Feb 14, 2022View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP and Chief Medical Officer
3,119$23.38$72.9K93,558Apr 1, 2021Apr 5, 2021View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP and Chief Medical Officer
1,542$25.95$40.0K96,677Feb 10, 2021Feb 12, 2021View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP and Chief Medical Officer
758$25.95$19.7K98,219Feb 10, 2021Feb 12, 2021View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
2,18798,977Jan 19, 2021Jan 22, 2021View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
36,96096,790Jan 19, 2021Jan 22, 2021View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
105,600105,600Jan 19, 2021Jan 21, 2021View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
36,96096,790Jan 19, 2021Jan 21, 2021View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
2,18798,977Jan 19, 2021Jan 21, 2021View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP and Chief Medical Officer
2,920$15.49$45.2K59,830Apr 1, 2020Apr 3, 2020View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
20,25062,750Feb 5, 2020Feb 7, 2020View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
22,50022,500Feb 5, 2020Feb 7, 2020View →
Other insiders · COLL
Loading peer insiders…
About this filer
CIK 0001772168
ROLE
EVP and Chief Medical Officer
PRIMARY
COLL
COMPANIES
2
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001772168DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback